Beyond readmission, 32.9% of patients with increased pancreatic necrosis volumes required additional invasive interventions.

The alerts resulted in an overall reduction of CT scans—down to 29.8% from 38.6%—and increased PECARN guideline adherence.

In the June 29 announcement, the ACR revealed CMS said the additional evidence provided to them was “insufficient” to support the reconsideration of their non-coverage decision.

Patients who received an injection had an infection rate of 2.2% at 4-month follow-up. In comparison, the infection rate for the general population in Massachusetts was 7.5% during the same period.